Literature DB >> 962488

Neuroendocrine regulation in depression. I. Limbic system-adrenocortical dysfunction.

G C Curtis, J Mendels.   

Abstract

The regulation of hypothalamopituitary-adrenal (HPA) function in depressed patients was studied by a midnight dexamethasone suppression test. By using an observation period of 24 hours postadministration of dexamethasone, a graded series of abnormal test responses was identified. Depressed patients show abnormal early escape from suppression rather than absolute resistance to HPA suppression by dexamethasone. With increasing severity of depression, this escape occurs progressively more early on the day after administration of dexamethasone. These abnormalities were strongly related to the presence of HPA hyperactivity before dexamethasone was given. The essential disturbance of neuroendocrine regulation in depression is a failure of the normal brain inhibitory influence on the HPA system. This disinhibition of HPA activity suggests that there is an abnormal limbic system drive on the HPA axis in primary depressive illness.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 962488     DOI: 10.1001/archpsyc.1976.01770090029002

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  53 in total

1.  Modeling the pharmacokinetics and pharmacodynamics of dexamethasone in depressed patients.

Authors:  S K Gupta; J C Ritchie; E H Ellinwood; K Wiedemann; F Holsboer
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 2.  Structural and synaptic plasticity in stress-related disorders.

Authors:  Daniel J Christoffel; Sam A Golden; Scott J Russo
Journal:  Rev Neurosci       Date:  2011       Impact factor: 4.353

3.  Using Cox cluster processes to model latent pulse location patterns in hormone concentration data.

Authors:  Nichole E Carlson; Gary K Grunwald; Timothy D Johnson
Journal:  Biostatistics       Date:  2015-11-09       Impact factor: 5.899

4.  Depressive symptoms during pregnancy: impact on neuroendocrine and neonatal outcomes.

Authors:  Sheila Marcus; Juan F Lopez; Susan McDonough; Michael J Mackenzie; Heather Flynn; Charles R Neal; Sheila Gahagan; Brenda Volling; Niko Kaciroti; Delia M Vazquez
Journal:  Infant Behav Dev       Date:  2010-10-29

Review 5.  [New insights into the pathogenesis and pathophysiology of depression].

Authors:  C Schüle; T C Baghai; R Rupprecht
Journal:  Nervenarzt       Date:  2007-11       Impact factor: 1.214

6.  Psychiatry-epitomes of progress: screening for endogenous depression: the dexamethasone suppression test.

Authors:  V I Reus
Journal:  West J Med       Date:  1981-02

Review 7.  Epilepsy, depression, and growth hormone.

Authors:  Tracy Butler; Patrick Harvey; Lila Cardozo; Yuan-Shan Zhu; Adam Mosa; Emily Tanzi; Fahad Pervez
Journal:  Epilepsy Behav       Date:  2019-02-14       Impact factor: 2.937

8.  Continuous administration of synthetic ovine corticotropin-releasing factor in man. Physiological and pathophysiological implications.

Authors:  H M Schulte; G P Chrousos; P W Gold; J D Booth; E H Oldfield; G B Cutler; D L Loriaux
Journal:  J Clin Invest       Date:  1985-06       Impact factor: 14.808

9.  Regulation of corticosteroid receptor gene expression in depression and antidepressant action.

Authors:  N Barden
Journal:  J Psychiatry Neurosci       Date:  1999-01       Impact factor: 6.186

Review 10.  The neurotrophic and neuroprotective effects of psychotropic agents.

Authors:  Joshua Hunsberger; Daniel R Austin; Ioline D Henter; Guang Chen
Journal:  Dialogues Clin Neurosci       Date:  2009       Impact factor: 5.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.